Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
HST Global Inc | 12.8M | -14.8x | --- |
Inhibitor Therapeutics Inc | 12.8M | -4.1x | --- |
NRX Pharmaceuticals Inc | 13.2M | -0.7x | --- |
Sensei Biotherapeutics Inc | 12.2M | -0.4x | --- |
NKGen Biotech Inc | 12.2M | -0.1x | --- |
PharmaCyte Biotech Inc | 13.4M | 3.5x | --- |
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 41.6M |
HST Global Inc does not pay a dividend. | |
Beta | -0.86 |
EPS | $-0.02 |
Book Value | $-0.11 |
P/E Ratio | -14.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.